US 11,744,494 B2
Blood contaminant sequestration device with one-way air valve and air-permeable blood barrier with closure mechanism
Bobby E. Rogers, San Diego, CA (US); Gino Kang, Irvine, CA (US); David Karl Stroup, San Diego, CA (US); Jonas Dean Cochran, Santee, CA (US); Arthur Deptala, Santee, CA (US); John Detloff, San Diego, CA (US); Lonnie Pogue, San Diego, CA (US); and Brian Macowski, San Diego, CA (US)
Assigned to KURIN, INC., San Diego, CA (US)
Filed by KURIN, INC.
Filed on Nov. 10, 2020, as Appl. No. 17/94,692.
Application 17/094,692 is a continuation of application No. 15/893,518, filed on Feb. 9, 2018, granted, now 10,827,964.
Claims priority of provisional application 62/467,016, filed on Mar. 3, 2017.
Claims priority of provisional application 62/457,764, filed on Feb. 10, 2017.
Prior Publication US 2021/0145336 A1, May 20, 2021
Int. Cl. A61B 5/00 (2006.01); A61B 5/15 (2006.01); A61B 5/153 (2006.01)
CPC A61B 5/150213 (2013.01) [A61B 5/153 (2013.01); A61B 5/15003 (2013.01); A61B 5/15074 (2013.01); A61B 5/150221 (2013.01); A61B 5/150251 (2013.01); A61B 5/150732 (2013.01); A61B 5/150992 (2013.01); A61B 5/150389 (2013.01); A61B 5/150503 (2013.01)] 43 Claims
OG exemplary drawing
 
1. A blood sample optimization device comprising:
an inlet port;
a junction coupled with the inlet port;
a chamber connected with the inlet port via the junction, the chamber configured to allow air to be displaced by a first portion of blood entering the inlet port, through the junction, and into the chamber;
an outlet port;
a sampling channel having a proximal end connected with the inlet port via the diverter junction and a distal end connected with the outlet port, the sampling channel being configured to convey subsequent portions of blood from the junction to the outlet port after the first portion of blood has entered the chamber; and
a housing that houses and defines the inlet port, the junction, the outlet port, the chamber, and the sampling channel.